143700-04-3

Basic information

• Product Name: (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate
• Synonyms: (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate
• CAS NO: 143700-04-3
• Molecular Weight: 212.252
• Mol File: 143700-04-3.mol

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate(143700-04-3)
• EPA Substance Registry System: (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate(143700-04-3)

Safety Data

• Hazardous Substances Data: 143700-04-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(R)-tert-butyl 3-azidopyrrolidine-1-carboxylate is used as a building block for the synthesis of various functionalized pyrrolidines. Its unique structure and reactivity allow for the creation of a wide range of compounds with different properties and applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (R)-tert-butyl 3-azidopyrrolidine-1-carboxylate is used as a precursor for the synthesis of bioactive molecules. Its potential applications in this area stem from its ability to be modified and incorporated into more complex molecular structures, which can then be evaluated for their therapeutic properties.
Used in Research and Development:
(R)-tert-butyl 3-azidopyrrolidine-1-carboxylate is also utilized in research and development, particularly for exploring new reaction pathways and understanding the reactivity of azidopyrrolidine carboxylates. This knowledge can be applied to the design and synthesis of novel compounds with potential applications in various industries, including pharmaceuticals, materials science, and chemical engineering.

Upstream product

• 139986-03-1 1,1-dimethylethyl-3(R)-{[(4-methylphenyl)sulphonyl]oxy}-1-pyrrolidinecarboxylate 
• 132945-75-6 (S)-tert-butyl 3-(methylsulfonyloxy)pyrrolidine-1-carboxylate 
• 109431-87-0 (R)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 371240-55-0 (S)-3-(toluene-4-sulfonyloxy)pyrrolidin-1-ylcarboxylic acid tert-butyl ester 
• 101469-92-5 (S)-3-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 147081-49-0 (R)-3-aminopyrrolidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

HETEROAROMATIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF

Disclosed are heteroaryl derivatives, pharmaceutical composition and uses in the manufacture of a medicine for treating respiratory diseases, especially for chronic obstructive pulmonary disease (COPD).

Aromatic heterocyclic derivatives and applications of aromatic heterocyclic derivatives in medicines

The present invention discloses aromatic heterocyclic derivatives and applications of the aromatic heterocyclic derivatives in medicines, and specifically provides a class of aromatic heterocyclic compounds or stereoisomers, geometric isomers, tautomers, racemic bodies, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof, and pharmaceutical compositions containing the compounds. The present invention further discloses uses of the compounds or pharmaceutical compositions in drug preparation, wherein the drug is used for treatment of respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).

4-Aminothiourea prolinol tert-butyldiphenylsilyl ether: A chiral secondary amine-thiourea as organocatalyst for enantioselective anti-mannich reactions

anti-Selective Mannich reactions of N-p-methoxyphenyl (PMP)-protected α-iminoglyoxylate with unmodified aldehydes or ketones were effectively catalyzed by 4-aminothiourea prolinol tert-butyldiphenylsilyl ether. The reactions led to chiral β-amino carbonyl compounds in high yields (up to 94%), excellent diastereo- and enantioselectivities (up to 98% de and >99% ee). The study demonstrated for the first time that direct Mannich-type reactions of unmodified aldehydes or ketones to aiminoglyoxylate can be promoted by secondary amine-thiourea chiral organocatalyst.

A convenient, high-yield synthesis of 1-substituted uracil and thymine derivatives

Novel reagents for the synthesis of 1-substituted uracil and thymine derivatives have been developed. The aminolysis of 2- or 4-nitrophenyl 3-ethoxyacryloylcarbamate and 3-ethoxy-2-methylacryloylcarbamate with a variety of primary amino derivatives procee

METHOD AND COMPOSITIONS FOR TREATING HIV INFECTIONS

Described herein are compounds and compositions that are useful in the treatment of HIV, AIDS, and AIDS-related diseases. In addition, compounds are described herein that are capable of inhibiting the dimerization of HIV proteases.